Skip to content
Back to Guavy Wire
Stocks

Amgen Expands Hyderabad Presence with New Research Centre

Instruments
AMGN
Share

Amgen, a global biotechnology company, is expanding its presence in Hyderabad by setting up a new research and innovation centre. The centre will be part of Amgen's global R&D network of seven research laboratories and will focus on discovery chemistry, drug metabolism, and precision medicine.

The MoU for the project was signed between Amgen India and the state government in the presence of IT Minister D Sridhar Babu at the Secretariat. According to officials, the centre is expected to become operational by 2027 and will create employment opportunities for highly skilled professionals.

Minister Sridhar Babu expressed his support for the project, stating that it would add momentum to Hyderabad's emergence as a global hub for advanced life sciences research. He also requested Amgen to give priority to local youth and talent from Telangana while recruiting for the centre.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc